Clinical Trial Update: Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events [Phase 3]

View source ↗

Summary

A Phase 3 trial update describes evaluating inclisiran added to maximally tolerated statin therapy for effects on atherosclerotic plaque progression in non-obst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Non-obstructive Coronary Artery Disease

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Coronary Artery Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING